Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
FDA Approves Keytruda in Both Adjuvant and Neoadjuvant Setting in High-Risk Early-Stage TNBCIn July 2021, the US FDA approved pembrolizumab (Keytruda) for high-risk, early-stage triple-negativ...
Hepion Pharma's NASH drug is set for Phase 2b after clearing the safety barHepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutic drugs fo...
UNITY Biotechnology declares positive data from phase 1 clinical trial of UBX1325 in Advanced Vascular Eye Disease patients UNITY Biotechnology, Inc., a biotechnology company developing t...
Insilico Medicine raises USD 255 Million for AI drug discoveryInsilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chem...
Mallinckrodt earns FDA nod for regenerative skin therapy for burnsMallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerat...
Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s d...
Pfizer suffers a DMD delay and halts BCMA trials amid safety woes Pfizer has paused after seeing three cases of peripheral neuropathy in an early-stage study, enrollment in a critical ana...
Arch Oncology scores USD 105 Million for anti-CD47 med in solid tumors, multiple myelomaArch Oncology scored USD 105 million from new and old backers to expand the drug’s journey through the c...
Vertex leads in CRISPR Therapeutics partnership with USD 900 Million upfrontVertex has boosted a deal with CRISPR Therapeutics to USD 900 million upfront as the companies compete against blueb...
Lilly’s RET inhibitor Retevmo exhibits early promise in new cancer typesThe phase 1/2 LIBRETTO-001 trial enrolled 32 patients with 12 unique RET fusion-positive advanced cancer types, comprisi...
A Learning Disability (LD) is a neurological condition resulting from genetic and neuro...
What is Gene Therapy and Is the Skin Suitable for Gene Therapy? Since its first discove...
Heart failure (HF), also referred to as Congestive Heart failure (CHF), is a condition ...
In advanced cancer patients, the most common site for the occurrence of metastasis is c...
Depression is a mental condition characterized by prolonged series of poor moods, loss ...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
.png)
